acetylene has been researched along with Triple Negative Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LJ; Cheng, W; Huang, M; Jiao, Y; Li, GB; Li, YP; Lin, WT; Lin, XD; Wei, YQ; Wu, XA; Xiang, R; Yang, J; Yang, SY; Zhang, CH; Zhang, RJ; Zhao, YL; Zheng, MW; Zhong, L | 1 |
1 other study(ies) available for acetylene and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer.
Topics: Acetylene; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Movement; Drug Design; Drug Screening Assays, Antitumor; Heterografts; Humans; Male; Mice, SCID; Neoplasm Transplantation; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; src-Family Kinases; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2015 |